Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 752

1.

Biomarker-Guided Tailored Therapy.

Lydiard J, Nemeroff CB.

Adv Exp Med Biol. 2019;1192:199-224. doi: 10.1007/978-981-32-9721-0_10.

PMID:
31705496
2.

Investigation of MORC1 DNA methylation as biomarker of early life stress and depressive symptoms.

Thomas M, Coope A, Falkenberg C, Dunlop BW, Czamara D, Provencal N, Craighead WE, Mayberg HS, Nemeroff CB, Binder EB, Nieratschker V.

J Psychiatr Res. 2020 Jan;120:154-162. doi: 10.1016/j.jpsychires.2019.10.019. Epub 2019 Oct 26.

PMID:
31683097
3.

The Devastating Clinical Consequences of Child Abuse and Neglect: Increased Disease Vulnerability and Poor Treatment Response in Mood Disorders.

Lippard ETC, Nemeroff CB.

Am J Psychiatry. 2019 Sep 20:appiajp201919010020. doi: 10.1176/appi.ajp.2019.19010020. [Epub ahead of print]

PMID:
31537091
4.

Differences in adverse childhood experiences (ACEs) and quality of physical and mental health between transgender and cisgender sexual minorities.

Schnarrs PW, Stone AL, Salcido R Jr, Baldwin A, Georgiou C, Nemeroff CB.

J Psychiatr Res. 2019 Dec;119:1-6. doi: 10.1016/j.jpsychires.2019.09.001. Epub 2019 Sep 6.

PMID:
31518909
5.

Association of Prospective Risk for Chronic PTSD Symptoms With Low TNFα and IFNγ Concentrations in the Immediate Aftermath of Trauma Exposure.

Michopoulos V, Beurel E, Gould F, Dhabhar FS, Schultebraucks K, Galatzer-Levy I, Rothbaum BO, Ressler KJ, Nemeroff CB.

Am J Psychiatry. 2019 Jul 29:appiajp201919010039. doi: 10.1176/appi.ajp.2019.19010039. [Epub ahead of print]

PMID:
31352811
6.

Convergent neurobiological predictors of mood and anxiety symptoms and treatment response.

Jabbi M, Nemeroff CB.

Expert Rev Neurother. 2019 Jun;19(6):587-597. doi: 10.1080/14737175.2019.1620604. Epub 2019 Jun 3.

PMID:
31096806
7.

The Effect of Early Life Stress on Adult Psychiatric Disorders.

Targum SD, Nemeroff CB.

Innov Clin Neurosci. 2019 Jan 1;16(1-2):35-37. Review.

8.

Recall accuracy for the symptoms of a major depressive episode among clinical trial participants.

Dunlop BW, Granros M, Lechner A, Mletzko-Crowe T, Nemeroff CB, Mayberg HS, Craighead WE.

J Psychiatr Res. 2019 Sep;116:178-184. doi: 10.1016/j.jpsychires.2019.03.008. Epub 2019 Mar 8.

PMID:
30878146
9.

EEG Biomarkers for Treatment Response Prediction in Major Depressive Illness.

Widge AS, Rodriguez CI, Carpenter LL, Kalin NH, McDonald W, Nemeroff CB.

Am J Psychiatry. 2019 Jan 1;176(1):82. doi: 10.1176/appi.ajp.2018.1760101. No abstract available.

PMID:
30848947
10.

Executive functioning in cognitively normal middle-aged offspring of late-onset Alzheimer's disease patients.

Abulafia C, Fiorentini L, Loewenstein DA, Curiel-Cid R, Sevlever G, Nemeroff CB, Villarreal MF, Vigo DE, Guinjoan SM.

J Psychiatr Res. 2019 May;112:23-29. doi: 10.1016/j.jpsychires.2019.02.016. Epub 2019 Feb 22.

PMID:
30836202
11.

Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.

Dunlop BW, LoParo D, Kinkead B, Mletzko-Crowe T, Cole SP, Nemeroff CB, Mayberg HS, Craighead WE.

Am J Psychiatry. 2019 Apr 1;176(4):275-286. doi: 10.1176/appi.ajp.2018.18091075. Epub 2019 Feb 15.

12.

DNA methylation levels are associated with CRF1 receptor antagonist treatment outcome in women with post-traumatic stress disorder.

Pape JC, Carrillo-Roa T, Rothbaum BO, Nemeroff CB, Czamara D, Zannas AS, Iosifescu D, Mathew SJ, Neylan TC, Mayberg HS, Dunlop BW, Binder EB.

Clin Epigenetics. 2018 Nov 3;10(1):136. doi: 10.1186/s13148-018-0569-x.

13.

Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease.

Duarte-Abritta B, Villarreal MF, Abulafia C, Loewenstein D, Curiel Cid RE, Castro MN, Surace E, Sánchez SM, Vigo DE, Vázquez S, Nemeroff CB, Sevlever G, Guinjoan SM.

J Psychiatr Res. 2018 Dec;107:11-18. doi: 10.1016/j.jpsychires.2018.10.008. Epub 2018 Oct 5.

PMID:
30308328
14.

Brain Structural and Amyloid Correlates of Recovery From Semantic Interference in Cognitively Normal Individuals With or Without Family History of Late-Onset Alzheimer's Disease.

Abulafia C, Loewenstein D, Curiel-Cid R, Duarte-Abritta B, Sánchez SM, Vigo DE, Castro MN, Drucaroff LJ, Vázquez S, Sevlever G, Nemeroff CB, Guinjoan SM, Villarreal MF.

J Neuropsychiatry Clin Neurosci. 2019 Winter;31(1):25-36. doi: 10.1176/appi.neuropsych.17120355. Epub 2018 Oct 11.

PMID:
30305005
15.

Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis.

Widge AS, Bilge MT, Montana R, Chang W, Rodriguez CI, Deckersbach T, Carpenter LL, Kalin NH, Nemeroff CB.

Am J Psychiatry. 2019 Jan 1;176(1):44-56. doi: 10.1176/appi.ajp.2018.17121358. Epub 2018 Oct 3.

PMID:
30278789
16.

Response rate profiles for major depressive disorder: Characterizing early response and longitudinal nonresponse.

Kelley ME, Dunlop BW, Nemeroff CB, Lori A, Carrillo-Roa T, Binder EB, Kutner MH, Rivera VA, Craighead WE, Mayberg HS.

Depress Anxiety. 2018 Oct;35(10):992-1000. doi: 10.1002/da.22832. Epub 2018 Sep 7.

17.

Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder.

Dunlop BW, Polychroniou PE, Rakofsky JJ, Nemeroff CB, Craighead WE, Mayberg HS.

Psychol Med. 2019 Aug;49(11):1869-1878. doi: 10.1017/S0033291718002568. Epub 2018 Sep 12.

PMID:
30207254
18.

Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response.

Syed SA, Beurel E, Loewenstein DA, Lowell JA, Craighead WE, Dunlop BW, Mayberg HS, Dhabhar F, Dietrich WD, Keane RW, de Rivero Vaccari JP, Nemeroff CB.

Neuron. 2018 Sep 5;99(5):914-924.e3. doi: 10.1016/j.neuron.2018.08.001. Epub 2018 Aug 23.

19.

Temporal Stability of Cognitive Functioning and Functional Capacity in Women with Posttraumatic Stress Disorder.

Gould F, Dunlop BW, Rosenthal JB, Iosifescu DV, Mathew SJ, Neylan TC, Rothbaum BO, Nemeroff CB, Harvey PD.

Arch Clin Neuropsychol. 2019 Jun 1;34(4):539-547. doi: 10.1093/arclin/acy064.

20.

Early Life Stress Associated With Increased Striatal N-Acetyl-Aspartate: Cerebrospinal Fluid Corticotropin-Releasing Factor Concentrations, Hippocampal Volume, Body Mass and Behavioral Correlates.

Coplan JD, Lu D, El Sehamy AM, Tang C, Jackowski AP, Abdallah CG, Nemeroff CB, Owens MJ, Mathew SJ, Gorman JM.

Chronic Stress (Thousand Oaks). 2018 Jan-Dec;2. doi: 10.1177/2470547018768450. Epub 2018 Apr 18.

21.

The Search for Treatments for Veterans With Major Depression: Of Paramount Importance, yet Still Elusive.

Nemeroff CB.

JAMA Psychiatry. 2018 Sep 1;75(9):877-878. doi: 10.1001/jamapsychiatry.2018.1591. No abstract available.

PMID:
29955814
22.

Interoception and Mental Health: A Roadmap.

Khalsa SS, Adolphs R, Cameron OG, Critchley HD, Davenport PW, Feinstein JS, Feusner JD, Garfinkel SN, Lane RD, Mehling WE, Meuret AE, Nemeroff CB, Oppenheimer S, Petzschner FH, Pollatos O, Rhudy JL, Schramm LP, Simmons WK, Stein MB, Stephan KE, Van den Bergh O, Van Diest I, von Leupoldt A, Paulus MP; Interoception Summit 2016 participants.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jun;3(6):501-513. doi: 10.1016/j.bpsc.2017.12.004. Epub 2017 Dec 28. Review.

23.

Correction to: Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling.

Zannas AS, Arloth J, Carrillo-Roa T, Iurato S, Röh S, Ressler KJ, Nemeroff CB, Smith AK, Bradley B, Heim C, Menke A, Lange JF, Brückl T, Ising M, Wray NR, Erhardt A, Binder EB, Mehta D.

Genome Biol. 2018 May 23;19(1):61. doi: 10.1186/s13059-018-1441-1.

24.

Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.

Zeier Z, Carpenter LL, Kalin NH, Rodriguez CI, McDonald WM, Widge AS, Nemeroff CB.

Am J Psychiatry. 2018 Sep 1;175(9):873-886. doi: 10.1176/appi.ajp.2018.17111282. Epub 2018 Apr 25.

25.

Drug Repositioning in Glioblastoma: A Pathway Perspective.

Tan SK, Jermakowicz A, Mookhtiar AK, Nemeroff CB, Schürer SC, Ayad NG.

Front Pharmacol. 2018 Mar 16;9:218. doi: 10.3389/fphar.2018.00218. eCollection 2018. Review.

26.

Ketamine: Quo Vadis?

Nemeroff CB.

Am J Psychiatry. 2018 Apr 1;175(4):297-299. doi: 10.1176/appi.ajp.2018.18010014. No abstract available.

PMID:
29606064
27.

Follow-up of monotherapy remitters in the PReDICT study: Maintenance treatment outcomes and clinical predictors of recurrence.

Kennedy JC, Dunlop BW, Craighead LW, Nemeroff CB, Mayberg HS, Craighead WE.

J Consult Clin Psychol. 2018 Feb;86(2):189-199. doi: 10.1037/ccp0000279.

PMID:
29369664
28.

Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder.

Dunlop BW, Cole SP, Nemeroff CB, Mayberg HS, Craighead WE.

J Affect Disord. 2018 Mar 15;229:111-119. doi: 10.1016/j.jad.2017.12.035. Epub 2017 Dec 27.

29.

Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity.

Carrillo-Roa T, Labermaier C, Weber P, Herzog DP, Lareau C, Santarelli S, Wagner KV, Rex-Haffner M, Harbich D, Scharf SH, Nemeroff CB, Dunlop BW, Craighead WE, Mayberg HS, Schmidt MV, Uhr M, Holsboer F, Sillaber I, Binder EB, Müller MB.

PLoS Biol. 2017 Dec 28;15(12):e2002690. doi: 10.1371/journal.pbio.2002690. eCollection 2017 Dec.

30.

Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.

O'Connell CP, Goldstein-Piekarski AN, Nemeroff CB, Schatzberg AF, Debattista C, Carrillo-Roa T, Binder EB, Dunlop BW, Craighead WE, Mayberg HS, Williams LM.

Am J Psychiatry. 2018 Mar 1;175(3):251-261. doi: 10.1176/appi.ajp.2017.17020172. Epub 2017 Dec 15.

31.

Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease.

Sánchez SM, Abulafia C, Duarte-Abritta B, de Guevara MSL, Castro MN, Drucaroff L, Sevlever G, Nemeroff CB, Vigo DE, Loewenstein DA, Villarreal MF, Guinjoan SM.

J Alzheimers Dis. 2017;60(3):1183-1193. doi: 10.3233/JAD-170491.

32.

The revolution of personalized psychiatry: will technology make it happen sooner?

Perna G, Grassi M, Caldirola D, Nemeroff CB.

Psychol Med. 2018 Apr;48(5):705-713. doi: 10.1017/S0033291717002859. Epub 2017 Oct 2.

PMID:
28967349
33.

The Structure of Personality Disorders within a Depressed Sample: Implications for Personalizing Treatment.

Berg JM, Kennedy JC, Dunlop BW, Ramirez CL, Stewart LM, Nemeroff CB, Mayberg HS, Craighead WE.

Pers Med Psychiatry. 2017 Mar-Apr;1-2:59-64. doi: 10.1016/j.pmip.2016.12.005. Epub 2017 Jan 5.

34.

Suicidal ideation and behavior in institutions of higher learning: A latent class analysis.

Bernanke J, Galfalvy HC, Mortali MG, Hoffman LA, Moutier C, Nemeroff CB, Stanley BH, Clayton P, Harkavy-Friedman J, Oquendo MA.

J Psychiatr Res. 2017 Dec;95:253-259. doi: 10.1016/j.jpsychires.2017.09.003. Epub 2017 Sep 9.

35.

Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder.

Dunlop BW, Binder EB, Iosifescu D, Mathew SJ, Neylan TC, Pape JC, Carrillo-Roa T, Green C, Kinkead B, Grigoriadis D, Rothbaum BO, Nemeroff CB, Mayberg HS.

Biol Psychiatry. 2017 Dec 15;82(12):866-874. doi: 10.1016/j.biopsych.2017.06.024. Epub 2017 Jul 4.

36.

Early Life Stress, Mood, and Anxiety Disorders.

Syed SA, Nemeroff CB.

Chronic Stress (Thousand Oaks). 2017 Feb;1. doi: 10.1177/2470547017694461. Epub 2017 Apr 10.

37.

Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.

Dunlop BW, Kelley ME, Aponte-Rivera V, Mletzko-Crowe T, Kinkead B, Ritchie JC, Nemeroff CB, Craighead WE, Mayberg HS; PReDICT Team.

Am J Psychiatry. 2017 Jun 1;174(6):546-556. doi: 10.1176/appi.ajp.2016.16050517. Epub 2017 Mar 24.

38.

Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.

Dunlop BW, Rajendra JK, Craighead WE, Kelley ME, McGrath CL, Choi KS, Kinkead B, Nemeroff CB, Mayberg HS.

Am J Psychiatry. 2017 Jun 1;174(6):533-545. doi: 10.1176/appi.ajp.2016.16050518. Epub 2017 Mar 24. Erratum in: Am J Psychiatry. 2017 Jun 1;174(6):604.

39.

Adult glucocorticoid receptor mRNA expression volatility in response to an acute stressor and juvenile CSF corticotropin-releasing factor: A pilot neurodevelopmental study.

Syed SA, Smith EL, Batuman O, Rosenblum LA, Owens MJ, Nemeroff CB, Coplan JD.

Neurosci Lett. 2017 Apr 24;647:20-25. doi: 10.1016/j.neulet.2017.03.017. Epub 2017 Mar 19.

PMID:
28330718
40.

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.

Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB; American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments.

JAMA Psychiatry. 2017 Apr 1;74(4):399-405. doi: 10.1001/jamapsychiatry.2017.0080. Review.

PMID:
28249076
41.

Amygdala Reactivity and Anterior Cingulate Habituation Predict Posttraumatic Stress Disorder Symptom Maintenance After Acute Civilian Trauma.

Stevens JS, Kim YJ, Galatzer-Levy IR, Reddy R, Ely TD, Nemeroff CB, Hudak LA, Jovanovic T, Rothbaum BO, Ressler KJ.

Biol Psychiatry. 2017 Jun 15;81(12):1023-1029. doi: 10.1016/j.biopsych.2016.11.015. Epub 2016 Dec 23.

42.

Reduced left ventricular dimension and function following early life stress: A thrifty phenotype hypothesis engendering risk for mood and anxiety disorders.

Coplan JD, Rozenboym AV, Fulton SL, Panthangi V, Tang J, Thiramangalakdi L, Perera TD, Liu Y, Kamran H, Owens MJ, Nemeroff CB, Rosenblum LA, Kral JG, Salciccioli L, Lazar J.

Neurobiol Stress. 2017 Jan 3;8:202-210. doi: 10.1016/j.ynstr.2017.01.001. eCollection 2018 Feb.

43.

Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants.

Goldstein-Piekarski AN, Korgaonkar MS, Green E, Suppes T, Schatzberg AF, Hastie T, Nemeroff CB, Williams LM.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11955-11960. Epub 2016 Oct 10.

44.

Personalized medicine: Prediction of disease vulnerability in mood disorders.

Prendes-Alvarez S, Nemeroff CB.

Neurosci Lett. 2018 Mar 16;669:10-13. doi: 10.1016/j.neulet.2016.09.049. Epub 2016 Oct 13. Review.

PMID:
27746310
45.

WHITHER KETAMINE AS AN ANTIDEPRESSANT: PANACEA OR TOXIN?

Newport DJ, Schatzberg AF, Nemeroff CB.

Depress Anxiety. 2016 Aug;33(8):685-8. doi: 10.1002/da.22535. No abstract available.

PMID:
27459676
46.

Lithium to the Rescue.

Jope RS, Nemeroff CB.

Cerebrum. 2016 Feb 1;2016. pii: cer-02-16. eCollection 2016 Jan-Feb.

47.

The Holy Grail of Psychiatry.

Nemeroff CB.

Cerebrum. 2015 Aug 1;2015. pii: cer-10-15. eCollection 2015 Jul-Aug.

48.

More Time for Science and Less Time for Administration?

Nemeroff CB, Rasgon N.

Neuropsychopharmacology. 2016 Oct;41(11):2625-6. doi: 10.1038/npp.2016.89. Epub 2016 Jun 9. No abstract available.

49.

Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.

Williams LM, Debattista C, Duchemin AM, Schatzberg AF, Nemeroff CB.

Transl Psychiatry. 2016 May 3;6:e799. doi: 10.1038/tp.2016.61.

50.

Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.

Menke A, Arloth J, Best J, Namendorf C, Gerlach T, Czamara D, Lucae S, Dunlop BW, Crowe TM, Garlow SJ, Nemeroff CB, Ritchie JC, Craighead WE, Mayberg HS, Rex-Haffner M, Binder EB, Uhr M.

Psychoneuroendocrinology. 2016 Jul;69:161-71. doi: 10.1016/j.psyneuen.2016.04.003. Epub 2016 Apr 14.

PMID:
27107207

Supplemental Content

Loading ...
Support Center